Vaccines Today has published a feature on the NOSEVAC project and its groundbreaking work on nasal vaccines, which could transform the way we prevent the spread of respiratory diseases. Unlike traditional injections, nasal vaccines stimulate the immune system directly in the nose and throat, the primary entry points for many viruses, potentially stopping infections before they take hold. 24 October 2025 “Vaccines don’t usually stop transmission, and that’s a big problem,” sa

As we celebrate European Immunisation Week, it's crucial to highlight the ongoing global efforts to protect people from respiratory infections.

The European Commission has endorsed IST_ID and NOSEVAC’s proposal to expand the project’s scope, allowing for new tasks and the...

The NOSEVAC project, co-funded by the European Commission and coordinated by European Vaccine Initiative (EVI), held its first annual...

The consortium aims to create nasal vaccines targeting S. pneumoniae and B. pertussis infections.

The new EVI-led project, NOSEVAC kick-off meeting, was successfully held for all involved partners on 16-17th May 2023 in Lille, France,...